Fundraising Fox

Spyre Therapeutics

NASDAQ: SYRE

2 known investors

spyre.com ↗

Spyre Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunology, aiming for more complete disease control, greater durability, and simpler treatment. Its pipeline targets validated mechanisms to treat gastrointestinal and rheumatic conditions in patients.

BiotechHealthtech

Investors · 2

Access BiotechnologyNew York City
Aisling CapitalNew York

Competitors · 1

by search overlap
Sarepta Therapeutics43 shared keywordsSarepta develops precision genetic medicines for people with rare diseases, with a focus on rare neuromuscular conditions. The company also runs an investigator-initiated studies program that funds independent clinical and non-clinical research in its therapeutic areas.

Companies competing with Spyre Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Spyre Therapeutics stock hits 52-week high at 108.16 USD By Investing.cominvesting.com · Aug 2026Spyre Therapeutics launches combination therapy trial for hidradenitis suppurativa By Investing.comca.investing.com · Aug 2026Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - BioSpacebiospace.com · Aug 2026Spyre Therapeutics (SYRE) Is Up 10.5% After Completing SKYWAY Enrollment and Expanding SPY003 Licensing Field - Simply Wall St Newssimplywall.st · Jun 2026Spyre Therapeutics Raises $463 Million to Fund IBD Clinical Programsharianbasis.co · Apr 2026Spyre Therapeutics Raises Capital Through Completed Stock Offering - TipRanks.comtipranks.com · Apr 2026

Frequently asked questions

What does Spyre Therapeutics do?
Spyre Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunology, aiming for more complete disease control, greater durability, and simpler treatment. Its pipeline targets validated mechanisms to treat gastrointestinal and rheumatic conditions in patients.
Who are Spyre Therapeutics's investors?
Spyre Therapeutics's investors include Access Biotechnology, Aisling Capital.